Cited by 773Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingNeurological disorders and treatments

Where Does Parkinson Disease Pathology Begin in the Brain?

Del Tredici, Kelly, Rüb, Udo, de Vos, Rob A.I., Bohl, Jürgen R.E., Braak, Heiko·2002·Journal of Neuropathology & Experimental Neurology

Abstract

The substantia nigra is not the induction site in the brain of the neurodegenerative process underlying Parkinson disease (PD). Instead, the results of this semi-quantitative study of 30 autopsy cases with incidental Lewy body pathology indicate that PD in the brain commences with the formation of the very first immunoreactive Lewy neurites and Lewy bodies in non-catecholaminergic neurons of the dorsal glossopharyngeus-vagus complex, in projection neurons of the intermediate reticular zone, and in specific nerve cell types of the gain setting system (coeruleus-subcoeruleus complex, caudal raphe nuclei, gigantocellular reticular nucleus), olfactory bulb, olfactory tract, and/or anterior olfactory nucleus in the absence of nigral involvement. The topographical parcellation of the nuclear grays described here is based upon known architectonic analyses of the human brainstem and takes into consideration the pigmentation properties of a few highly susceptible nerve cell types involved in PD. In this sample and in all 58 age- and gender-matched controls, Lewy bodies and Lewy neurites do not occur in any of the known prosencephalic predilection sites (i.e. hippocampal formation, temporal mesocortex, proneocortical cingulate areas, amygdala, basal nucleus of Meynert, interstitial nucleus of the diagonal band of Broca, hypothalamic tuberomamillary nucleus).

Integrity signals

Registry

Crossref · 10.1093/jnen/61.5.413

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Del Tredici, K., Rüb, U., de Vos, R. A. I., Bohl, J. R. E., & Braak, H.
Affiliations
Goethe University Frankfurt (DE)
Venue
Journal of Neuropathology & Experimental Neurology
Published
2002-05
Volume
61
Issue
5
Pages
413-426
ISSN
  • 0022-3069 (ISSN-L)
  • 1554-6578
OpenAlex
W1237068170
Cited by
773
References
6
Citations by year
2026: 15 · 2025: 23 · 2024: 30 · 2023: 28 · 2022: 45 · 2021: 26 · 2020: 37 · 2019: 52 · 2018: 27 · 2017: 44 · 2016: 27 · 2015: 40 · 2014: 19 · 2013: 31 · 2012: 34
FWCI
15.71
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Neuropathology & Experimental Neurology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
  • Health Sciences › Medicine › Neurology › Neurological disorders and treatments
Keywords
Parkinson's disease, Lewy bodies, Lewy neurites, substantia nigra, gigantocellular reticular nucleus, olfactory bulb, olfactory tract, anterior olfactory nucleus, brainstem
MeSH terms
Aged, Aged, 80 and over, Female, Glossopharyngeal Nerve, Humans, Locus Coeruleus, Male, Nerve Tissue Proteins, Olfactory Bulb, Olfactory Pathways, Parkinson Disease, Raphe Nuclei, Reticular Formation, Substantia Nigra, Vagus Nerve, Lewy Bodies, Synucleins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review